BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2522385)

  • 1. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
    Weintraub SJ; Eschenbacher WL
    Chest; 1989 Apr; 95(4):861-4. PubMed ID: 2522385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
    LeDoux EJ; Morris JF; Temple WP; Duncan C
    Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ipratropium bromide in asthma. Results of a multi-clinic study.
    Storms WW; Bodman SF; Nathan RA; Busse WW; Bush RK; Falliers CJ; O'Hollaren JD; Weg JG
    Am J Med; 1986 Nov; 81(5A):61-6. PubMed ID: 2947462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
    Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
    Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
    Karpel JP
    Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
    Karpel JP; Pesin J; Greenberg D; Gentry E
    Chest; 1990 Oct; 98(4):835-9. PubMed ID: 2145136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
    Tashkin DP; Bleecker E; Braun S; Campbell S; DeGraff AC; Hudgel DW; Boyars MC; Sahn S
    Am J Med; 1996 Jan; 100(1A):62S-69. PubMed ID: 8610720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of various combinations of ipratropium bromide and metaproterenol in allergic asthmatic patients.
    Bruderman I; Cohen-Aronovski R; Smorzik J
    Chest; 1983 Feb; 83(2):208-10. PubMed ID: 6217951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatic subjects.
    Salome CM; Wright W; Sedgwick CJ; Woolcock AJ
    Prog Clin Biol Res; 1988; 263():405-19. PubMed ID: 2967977
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of oxitropium bromide and ipratropium bromide in asthma.
    Peel ET; Anderson G; Cheong B; Broderick N
    Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitussive properties of inhaled bronchodilators on induced cough.
    Lowry R; Wood A; Johnson T; Higenbottam T
    Chest; 1988 Jun; 93(6):1186-9. PubMed ID: 2967164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ipratropium bromide on lung function in patients with cystic fibrosis].
    Wiebicke W; Poynter A; Montgomery M; Pagtakhan R
    Pneumologie; 1990 Feb; 44 Suppl 1():277-8. PubMed ID: 2142293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bronchodilator effects of Duovent and Reproterol in patients with chronic reversible airway obstruction.
    Baronti A; Grieco A; Lelli M; Virgili G
    Respiration; 1986; 50 Suppl 2():173-6. PubMed ID: 2951800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by ipratropium bromide and metaproterenol against methacholine and histamine bronchoconstriction.
    Nair N; Townley RG; Watt G; Schlanger S; Bewtra AK; Stekoll LH
    Clin Allergy; 1984 Jan; 14(1):11-9. PubMed ID: 6230176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined bronchodilator protection against histamine-induced bronchoconstriction in man.
    Ruffin RE; Meki M; Alpers JH
    Clin Exp Pharmacol Physiol; 1987 Feb; 14(2):87-94. PubMed ID: 2955980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
    Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
    Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
    Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.